A Phase II Sequential Dose-escalation Study Evaluating the Safety and Feasibility of Allogenlc Umbillcal Cord Derived Mesenchymal Stromal Cells for the Treatment of Adults w/ Treatment Refractory Lupus Dr. Rosalind Ramsey-Goldman - Rheumatology (Medical U

Northwestern University will be a clinical site for a planned clinical trial and will enroll 13 participants in the trial by interacting with the trial PI and co-investigators and complete all CRFs, comply with data management and analysis plans for the trial and also complete site specific tasks such as the local IRB and research unit applications, budget and clean cell facility utilization.